Bioabsorbable Stents Market Report by Biomaterial (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), E

Bioabsorbable Stents Market Report by Biomaterial (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Centers), and Region 2024-2032


The global bioabsorbable stents market size reached US$ 409.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 764.2 Million by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.

Bioabsorbable stents (BRS) are coated with an antiproliferative drug or gene that dissolves over time to restore vessel patency and permit remodeling while retaining recoil. It helps in regulating blood flow at branch points and limiting the amount of blood to areas of the vascular network while maintaining the flow at low perfusion. It also improves lesion imaging with cardiac computed tomography (CT) and magnetic resonance imaging (MRI). In addition, it leaves no residual scaffold, reduces vessel irritation and inflammation, and facilitates repeat treatments to the same site. As a result, BRS finds extensive applications in hospitals and cardiac centers across the globe.

Bioabsorbable Stents Market Trends:
The growing prevalence of cardiovascular diseases due to an unhealthy diet, physical inactivity, and excessive consumption of tobacco and alcohol represents one of the factors driving the market. Moreover, there is a rise in the utilization of percutaneous coronary intervention (PCI) procedures to open a blocked artery for carrying oxygen-rich blood through the body. This, along with the expanding healthcare industry, is contributing to the growth of the market. Besides this, the increasing awareness among the masses about the benefits of bioabsorbable stents is offering lucrative growth opportunities to industry investors. In addition, the growing demand for minimally invasive procedures due to less postoperative pain, fewer operative and postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce SLENDER integrated delivery system (IDS) fixed-wire and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems to treat coronary artery disease. They are also focusing on developing polymer-based stents, which is expected to bolster the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bioabsorbable stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on biomaterial, absorption rate, application and end user.

Breakup by Biomaterial:

Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents

Breakup by Absorption Rate:

Slow-Absorption Stents
Fast-Absorption Stents

Breakup by Application:

Coronary Artery Disease
Peripheral Artery Disease

Breakup by End User:

Hospitals
Cardiac Centers

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arterius Limited, B. Braun SE, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Reva Medical LLC and Terumo Corporation.

Key Questions Answered in This Report

1. What was the size of the global bioabsorbable stents market in 2023?
2. What is the expected growth rate of the global bioabsorbable stents market during 2024-2032?
3. What are the key factors driving the global bioabsorbable stents market?
4. What has been the impact of COVID-19 on the global bioabsorbable stents market?
5. What is the breakup of the global bioabsorbable stents market based on the biomaterial?
6. What is the breakup of the global bioabsorbable stents market based on the absorption rate?
7. What is the breakup of the global bioabsorbable stents market based on the application?
8. What is the breakup of the global bioabsorbable stents market based on the end user?
9. What are the key regions in the global bioabsorbable stents market?
10. Who are the key players/companies in the global bioabsorbable stents market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bioabsorbable Stents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Biomaterial
6.1 Polymer-based Bioabsorbable Stents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Metal-based Bioabsorbable Stents
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Absorption Rate
7.1 Slow-Absorption Stents
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Fast-Absorption Stents
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Coronary Artery Disease
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Peripheral Artery Disease
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cardiac Centers
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Arterius Limited
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 B. Braun SE
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biotronik SE & Co. KG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 Boston Scientific Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Elixir Medical Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Kyoto Medical Planning Co. Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Meril Life Sciences Pvt. Ltd.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Reva Medical LLC
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Terumo Corporation
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings